Standard BioTools, Inc. (LAB)
0.7225
+0.03
(+4.41%)
USD |
NASDAQ |
Sep 09, 13:06
Standard BioTools Total Liabilities (Quarterly) : 87.25M for June 30, 2026
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 87.25M |
| March 31, 2026 | 77.99M |
| December 31, 2025 | 143.46M |
| September 30, 2025 | 139.98M |
| June 30, 2025 | 132.43M |
| March 31, 2025 | 125.00M |
| December 31, 2024 | 140.62M |
| September 30, 2024 | 192.21M |
| June 30, 2024 | 198.47M |
| March 31, 2024 | 200.35M |
| December 31, 2023 | 159.86M |
| September 30, 2023 | 471.00M |
| June 30, 2023 | 469.21M |
| March 31, 2023 | 468.81M |
| December 31, 2022 | 160.52M |
| September 30, 2022 | 477.66M |
| June 30, 2022 | 478.58M |
| March 31, 2022 | 249.82M |
| December 31, 2021 | 180.62M |
| September 30, 2021 | 182.85M |
| June 30, 2021 | 179.86M |
| March 31, 2021 | 182.26M |
| December 31, 2020 | 185.71M |
| September 30, 2020 | 171.00M |
| June 30, 2020 | 149.63M |
| Date | Value |
|---|---|
| March 31, 2020 | 148.72M |
| December 31, 2019 | 111.20M |
| September 30, 2019 | 106.79M |
| June 30, 2019 | 111.15M |
| March 31, 2019 | 109.20M |
| December 31, 2018 | 231.53M |
| September 30, 2018 | 229.88M |
| June 30, 2018 | 224.27M |
| March 31, 2018 | 221.13M |
| December 31, 2017 | 256.42M |
| September 30, 2017 | 252.93M |
| June 30, 2017 | 254.77M |
| March 31, 2017 | 253.96M |
| December 31, 2016 | 253.16M |
| September 30, 2016 | 252.45M |
| June 30, 2016 | 257.77M |
| March 31, 2016 | 255.46M |
| December 31, 2015 | 256.16M |
| September 30, 2015 | 254.36M |
| June 30, 2015 | 255.91M |
| March 31, 2015 | 252.58M |
| December 31, 2014 | 257.14M |
| September 30, 2014 | 255.84M |
| June 30, 2014 | 255.92M |
| March 31, 2014 | 257.29M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Illumina, Inc. | 3.812B |
| Agilent Technologies, Inc. | 6.604B |
| Bio-Rad Laboratories, Inc. | 3.078B |
| Bruker Corp. | 3.617B |
| Danaher Corp. | 39.78B |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 627.22M |
| Shareholders Equity (Quarterly) | 539.97M |
| Debt to Equity Ratio | 0.052 |
| Current Ratio | 9.100 |
| Net Debt Paydown Yield | 0.21% |